Skip to main content

Advertisement

SpringerLink
Log in

CANCER IMMUNOTHERAPY

Strengthening the sting of immunotherapy

  • Research Highlight
  • Published:

From Nature Reviews Immunology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original articles

  • Chin, E. N. et al. Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science 369, 993–999 (2020)

    CAS  PubMed  Google Scholar 

  • Pan, B.-S. et al. An orally available non-nucleotide STING agonist with antitumor activity. Science 369, eaba6098 (2020)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Senior Editor, Nature Reviews Drug Discovery http://www.nature.com/nri/

    Sarah Crunkhorn

Authors
  1. Sarah Crunkhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah Crunkhorn.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crunkhorn, S. Strengthening the sting of immunotherapy. Nat Rev Immunol 20, 589 (2020). https://doi.org/10.1038/s41577-020-00447-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41577-020-00447-1

  • Springer Nature Limited

This article is cited by

Search

Navigation